Skip to main content

Table 2 The patient’s ward

From: Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients

Ward Male (cases) Female (cases) Age (years)
The first infectious disease department, ward 4 (A4) 15 23 55.50 ± 14.16
The first infectious disease department, ward 8 (A8) 29 23 58.01 ± 13.06
The first infectious disease department, ward 13 (A13) 24 22 64.56 ± 14.01
The second infectious disease department, ward 1 (B1) 36 30 69.35 ± 16.85